The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Multimodal Imaging Market During The Forecast Period?

The multimodal imaging market has experienced robust growth in recent years. It is projected to expand from $4.32 billion in 2025 to $4.61 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.6%. This historical expansion is largely due to factors such as the proliferation of advanced diagnostic imaging techniques, the increase in cancer screening initiatives, the enhancement of hospital imaging facilities, advancements in detector technology, and elevated demand for clinical imaging services.

The multimodal imaging sector is poised for substantial growth in the upcoming years. It is forecast to achieve a valuation of $6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This expansion during the forecast period is fueled by an escalating demand for precision diagnostics, a growing burden of chronic diseases, the adoption of AI in imaging analytics, the development of hybrid imaging systems, and the broadening of imaging as a service. Noteworthy trends for this period include hybrid PET/MR imaging systems, integrated multi-modality diagnostics, AI-assisted image fusion, cloud-based imaging analytics, and advanced multimodal visualization software.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33234&type=smp

What Influential Factors Are Boosting The Multimodal Imaging Market Demand?

The increasing need for prompt and precise identification of diseases is projected to drive the expansion of the multimodal imaging market in the future. This refers to the method of identifying illnesses in their initial phases with great accuracy, leveraging medical data and advanced technologies to facilitate prompt treatment and improved patient results. The increase in early and accurate disease diagnosis stems from individuals desiring quick and exact detection of ailments for enhanced treatment and outcomes, allowing medical practitioners to identify conditions significantly earlier than previously possible. Multimodal imaging aids in early and accurate disease diagnosis by enabling the integration of various medical imaging methods for more precise disease detection. For example, data from October 2024, provided by the National Health Service England, a UK-based public body, indicated that by March 2024, early diagnosis rates had risen to 2.4% points above pre-pandemic levels and were 0.8% points higher than the preceding year, as per Rapid Cancer Registration Data. Consequently, the escalating demand for early and accurate disease diagnosis is propelling the expansion of the multimodal imaging market.

What Key Segment Areas Are Included In The Multimodal Imaging Market Assessment?

The multimodal imaging market covered in this report is segmented –

1) By Product: Multimodal Imaging Equipment; Reagents; Software

2) By Technology: Positron Emission Tomography (PET) Or Computed Tomography (CT) Systems; Single Photon Emission Computed Tomography Or Computed Tomography (CT) Systems; Positron Emission Tomography (PET) Or Magnetic Resonance (MR) Systems; Other Technologies

3) By Application: Oncology; Cardiology; Neurology; Ophthalmology; Musculoskeletal Disorders; Other Applications

4) By End-User: Hospitals; Diagnostic Imaging Centers; Other End-Users

Subsegments:

1) By Multimodal Imaging Equipment: Magnetic Resonance Imaging Scanner; Computed Tomography Scanner; Positron Emission Tomography Scanner; Single Photon Emission Computed Tomography Scanner; Optical Imaging System; Photoacoustic Imaging System; Hybrid Imaging System

2) By Reagents: Contrast Agents; Radiopharmaceuticals; Fluorescent Dyes; Molecular Probes

3) By Software: Image Processing Software; Analysis And Visualization Software; Data Management Software; Workflow And Reporting Software

Which Trends Are Supporting The Evolution Of The Multimodal Imaging Market?

Leading companies in the multimodal imaging market are increasingly focusing on advancements in artificial intelligence and machine learning for image analysis and interpretation. This includes innovations like AI-assisted image segmentation, which enables the automated identification of anatomical structures and regions of interest across various imaging modalities. AI-assisted image segmentation itself refers to the application of artificial intelligence algorithms to automatically divide images into meaningful sections, a process that traditionally required manual tracing by human experts. For example, in September 2025, Revvity, Inc., a US-based company specializing in preclinical imaging solutions, introduced its Living Image Synergy AI multimodal analysis software. This particular software provides a unified, AI-enabled platform designed for the seamless analysis of in vivo imaging data across optical, microCT, ultrasound, and other modalities. It works to reduce data inconsistencies by centralizing workflows and eliminating the necessity for multiple standalone tools. Additionally, the software integrates advanced AI algorithms to automate image segmentation and region-of-interest quantification, thereby improving both accuracy and reproducibility. Intuitive co-registration and automated processes further serve to minimize manual effort and analysis time.

Who Are The Firms Contributing To The Multimodal Imaging Market Ecosystem?

Major companies operating in the multimodal imaging market are Samsung Medison Co. Ltd., Analogic Corporation, Alcon Inc., Hologic Inc., Sofie Biosciences Inc., ShanghAI United Imaging Healthcare Co. Ltd., Topcon Corporation, Agfa-Gevaert Group, Heidelberg Engineering GmbH, Optos plc, RefleXion Medical Inc., Neusoft Corporation, Infraredx Inc., MinFound Medical Systems Co. Ltd., Neusoft Medical Systems Co. Ltd., Spectrum Dynamics Medical LLC, Konica Minolta Healthcare Americas Inc., Esaote S.p.A., MR Solutions Ltd., MILabs B.V., NIDEK Co. Ltd., Kowa Company Ltd., and Positron Corporation.

Access The Complete Multimodal Imaging Market Report:

https://www.thebusinessresearchcompany.com/report/multimodal-imaging-market-report

Which Geographic Region Represents The Largest Multimodal Imaging Market Share?

North America was the largest region in the multimodal imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multimodal imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Multimodal Imaging Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model